iShares Health Innovation Active ETF (NYSEARCA:BMED) Short Interest Down 73.2% in August

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the recipient of a large drop in short interest during the month of August. As of August 14th, there was short interest totaling 2,154 shares, a drop of 73.2% from the July 30th total of 8,033 shares. Based on an average daily volume of 2,286 shares, the short-interest ratio is currently 0.9 days. Currently, 0.6% of the company’s shares are short sold.

Institutional Investors Weigh In On iShares Health Innovation Active ETF

A hedge fund recently bought a new position in iShares Health Innovation Active ETF stock. Comprehensive Financial Planning Inc. PA bought a new position in shares of iShares Health Innovation Active ETF (NYSEARCA:BMED) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 10,832 shares of the company’s stock, valued at approximately $309,000. Comprehensive Financial Planning Inc. PA owned approximately 3.01% of iShares Health Innovation Active ETF at the end of the most recent quarter.

iShares Health Innovation Active ETF Stock Down 1.8%

NYSEARCA BMED traded down $0.62 on Friday, reaching $33.88. The stock had a trading volume of 1,014 shares, compared to its average volume of 3,413. The stock has a fifty day moving average price of $31.57 and a two-hundred day moving average price of $29.85. iShares Health Innovation Active ETF has a 12-month low of $25.79 and a 12-month high of $34.86. The firm has a market capitalization of $12.20 million, a price-to-earnings ratio of 24.91 and a beta of 0.73.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.